Biotech & Life SciencesMobility & TransportationHealthcareFood & AgricultureGamingMedia & EntertainmentSocial & Community
Woodline Partners is a hedge fund that employs a market-neutral, long/short equity strategy, focusing on generating "idiosyncratic alpha" through bottom-up fundamental research. They primarily invest in the healthcare, technology, and industrial sectors, utilizing shorts to hedge market risk.
50% of their portfolio is in Biotech & Life Sciences. Deal activity decreased year-over-year (2 deals in the last 12 months vs 3 prior). Their most common stage is series-b (42% of deals). Average disclosed round size is $148.2M (across 11 rounds with reported amounts).
Portfolio
12
Fund Size
—
Top Stage
Series B
Last 12 Mo
2
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
12 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Skyryse | Series C | — | Feb 2026 |
| SSAB Biotherapeutics, Inc. | Series B | $175M | Jul 2025 |
 Elektrofi, Inc. | Series C | $112.3M | Oct 2024 |
 Blue Earth Therapeutics Ltd | Series A | $76.5M | Oct 2024 |
 Formo | Series B | $61M | Sep 2024 |
| BBuild A Rocket Boy | Series D | $110M | Jan 2024 |
 Odyssey Therapeutics, Inc. | Series B | $168M | Oct 2022 |
| Odyssey Therapeutics, Inc. | Series A | $218M | Dec 2021 |
 Arbor Biotechnologies Inc | Series B | $215M | Nov 2021 |
 SmartNews | Series F | $230M | Sep 2021 |
 Affinia Therapeutics | Series B | $110M | May 2021 |
 Patreon | Growth | $155M | Apr 2021 |
Top Co-Investors
Logos Capital4 shared
RA Capital Management3 shared
SR One3 shared
NEA (New Enterprise Associates)2 shared
OrbiMed2 shared
Foresite Capital2 shared
HBM Healthcare Investment2 shared
Colt Ventures2 shared
ArrowMark Partners2 shared
Deep Track Capital2 shared
Janus Henderson Investors2 shared
General Catalyst2 shared
Catalio Capital Management2 shared
Princeville Capital1 shared
JIC Venture Growth Investments1 shared
ACA Investments1 shared
Green Co-Invest Investment1 shared
Yamauchi-No.10 Family Office1 shared
SMBC Venture Capital1 shared
Last updated: 16 April 2026